Table 3 Pathology of the primary tumor and different routes of delivery of 3 sclerosing agents for 104 cases with malignant pleural effusion
From: Chemical pleurodesis for malignant pleural effusion: which agent is perfect?
Pathology of the primary tumor | Bleomycin (n = 43) | Doxycycline (n = 36) | Betadine (n = 25) | Total | |||
|---|---|---|---|---|---|---|---|
Chest tube and bleomycin | Pig-tail and bleomycin | Chest tube and doxycycline | Pig-tail and doxycycline | Chest tube and betadine | Pig-tail and betadine | Total n (%) | |
Bronchogenic carcinoma | 6 | 5 | 2 | 4 | 5 | 0 | 22 (21.2) |
Hepatoma | 4 | 2 | 1 | 3 | 2 | 0 | 12 (11.5) |
Cancer breast | 4 | 4 | 4 | 2 | 6 | 0 | 20 (19.2) |
Osteosarcoma | 3 | 0 | 0 | 3 | 0 | 0 | 6 (5.8) |
Colorectal | 3 | 0 | 0 | 3 | 3 | 0 | 9 (8.7) |
Mesothelioma | 3 | 0 | 0 | 2 | 1 | 0 | 6 (5.8) |
Ovarian | 3 | 0 | 1 | 2 | 2 | 0 | 8 (7.7) |
Lymphoma | 2 | 1 | 2 | 2 | 1 | 2 | 10 (9.6) |
Kidney | 1 | 0 | 0 | 2 | 0 | 0 | 3 (2.9) |
Thymoma | 1 | 0 | 1 | 0 | 0 | 1 | 3 (2.9) |
Esophageal | 0 | 0 | 1 | 0 | 1 | 0 | 2 (1.9) |
Unknown primary | 0 | 1 | 0 | 1 | 1 | 0 | 3 (2.9) |
Total n(%) | 30 (28.8) | 13 (12.5) | 12 (11.5) | 24 (23.1) | 22 (21.1) | 3 (2.9) | 104 |